360 related articles for article (PubMed ID: 11433225)
1. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis.
Visentin GP; Moghaddam M; Beery SE; McFarland JG; Aster RH
J Lab Clin Med; 2001 Jul; 138(1):22-31. PubMed ID: 11433225
[TBL] [Abstract][Full Text] [Related]
2. Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody.
Li ZQ; Liu W; Park KS; Sachais BS; Arepally GM; Cines DB; Poncz M
Blood; 2002 Feb; 99(4):1230-6. PubMed ID: 11830470
[TBL] [Abstract][Full Text] [Related]
3. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
4. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
5. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
7. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
Visentin GP; Ford SE; Scott JP; Aster RH
J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
[TBL] [Abstract][Full Text] [Related]
8. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: platelet factor 4.
Suh JS; Aster RH; Visentin GP
Blood; 1998 Feb; 91(3):916-22. PubMed ID: 9446652
[TBL] [Abstract][Full Text] [Related]
9. Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.
Johnston I; Sarkar A; Hayes V; Koma GT; Arepally GM; Chen J; Chung DW; López JA; Cines DB; Rauova L; Poncz M
Blood; 2020 Apr; 135(15):1270-1280. PubMed ID: 32077913
[TBL] [Abstract][Full Text] [Related]
10. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia.
Greinacher A; Fürll B; Selleng S
Methods Mol Biol; 2013; 992():301-18. PubMed ID: 23546723
[TBL] [Abstract][Full Text] [Related]
12. Testing for heparin-induced thrombocytopenia antibodies.
Warkentin TE; Sheppard JA
Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
[TBL] [Abstract][Full Text] [Related]
13. Further characterization of antibody and antigen in heparin-induced thrombocytopenia.
Newman PM; Chong BH
Br J Haematol; 1999 Nov; 107(2):303-9. PubMed ID: 10583216
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
15. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
[TBL] [Abstract][Full Text] [Related]
16. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
[TBL] [Abstract][Full Text] [Related]
17. Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.
Litvinov RI; Yarovoi SV; Rauova L; Barsegov V; Sachais BS; Rux AH; Hinds JL; Arepally GM; Cines DB; Weisel JW
J Biol Chem; 2013 Nov; 288(46):33060-70. PubMed ID: 24097975
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune heparin-induced thrombocytopenia.
Greinacher A; Selleng K; Warkentin TE
J Thromb Haemost; 2017 Nov; 15(11):2099-2114. PubMed ID: 28846826
[TBL] [Abstract][Full Text] [Related]
19. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia.
Ziporen L; Li ZQ; Park KS; Sabnekar P; Liu WY; Arepally G; Shoenfeld Y; Kieber-Emmons T; Cines DB; Poncz M
Blood; 1998 Nov; 92(9):3250-9. PubMed ID: 9787161
[TBL] [Abstract][Full Text] [Related]
20. Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.
Tutwiler V; Madeeva D; Ahn HS; Andrianova I; Hayes V; Zheng XL; Cines DB; McKenzie SE; Poncz M; Rauova L
Blood; 2016 Jan; 127(4):464-72. PubMed ID: 26518435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]